Institut Paoli-Calmettes: Hematologic Neoplasms trials
The registry lists 11 Hematologic Neoplasms studies with Institut Paoli-Calmettes as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 2Phase 3 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Feasibility Study of a Sports-Inspired Onco-Coaching Progranm for Young Adults i Cancer RemissionRecruitingNCT07861971
- PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUMNot yet recruitingNCT06066255Phase 2
- Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment ResistanceNot yet recruitingNCT05602168Not applicable
- Immunological Profile for Patients Treated With CAR-T CellsNot yet recruitingNCT05054231Not applicable
- TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRSStatus unknownNCT04822974Not applicable
- An Evaluation of Patients Access to Their Electronic Medical Records Via the IPC Connect ApplicationStatus unknownNCT04496375
- Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016CompletedNCT03469921
- Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell TransplantationStatus unknownNCT02921685Phase 1
- Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly PatientsCompletedNCT02623309Phase 3
- Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell TransplantationCompletedNCT01853358Phase 1
- A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic TransplantationCompletedNCT00894049Phase 2